STOKE THERAPEUTICS INC (STOK)
US86150R1077 - Common Stock
STOK Stock Earnings: Stoke Therapeutics Beats EPS, Beats Revenue for Q1 2024
STOK stock results show that Stoke Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
STOK Stock Earnings: Stoke Therapeutics Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Stoke Therapeutics (NASDAQ:STOK) just reported results for the first quarter of...
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer
Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Commit To Buy Stoke Therapeutics At $10, Earn 26.8% Annualized Using Options
Investors Snag STOK 9.6% Cheaper Than Its Secondary Stock Offering
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
Notable Tuesday Option Activity: DNUT, RH, STOK
Stoke Therapeutics Announces Proposed Public Offering
Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?
NeuBase Therapeutics stock is down on Tuesday as NBSE investors react to details concerning an upcoming special shareholder meeting.
Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket
Shares of Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase 1/2a data supporting the potential for STK-001
Why Is Check-Cap (CHEK) Stock Up 44% Today?
Check-Cap stock is up on Tuesday with heavy trading as CHEK investors react to news of a business combination with Nobul AI.
Why Is Stoke Therapeutics (STOK) Stock Up 99% Today?
Stoke Therapeutics stock is up on Tuesday as STOK shares see heavy trading alongside recent positive clinical trial data.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to dive into the biggest pre-market stock movers on Tuesday as we check out all of the hottest news moving shares this morning!
STOK Stock Earnings: Stoke Therapeutics Beats EPS, Misses Revenue for Q4 2023
STOK stock results show that Stoke Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
STOK Stock Earnings: Stoke Therapeutics Beats EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Stoke Therapeutics (NASDAQ:STOK) just reported results for the fourth quarter o...
Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Stoke Therapeutics (STOK) Shares Cross Above 200 DMA
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.